COVID-19: Are markets mispricing the risk?

With recent highs on global equity indices, IGTV’s Jeremy Naylor asked Dr Navid Malik, Head of Life Sciences Research at The Life Sciences Division, whether investors and traders are getting ahead of themselves in pricing risk. Dr Malik, as well as being a medical doctor and an expert in COVID-19, is also an investor and runs the research desk at The Life Sciences Division.

In this episode, the discussion begins with the recent developments on how the virus seems to be mutating and then moves onto the ways in which pharma and biotech companies are rising to the challenge.

Any opinion, news, research, analysis, or other information does not constitute investment or trading advice.

Follow us on Twitter @IGcom